Genetic Analysis announces final outcome of the subsequent offering to existing shareholders 2023-12-27
Genetic Analysis announces preliminary outcome of the subsequent offering to existing shareholders 2023-12-272023-12-22
Genetic Analysis summarizes this year’s product development activities and looks ahead to 2024 2023-12-13
Genetic Analysis publishes information memorandum relating to the previously announced subsequent offering 2023-12-112023-12-08
Genetic Analysis announces final number of subscription rights received per existing share in the previously announced subsequent offering 2023-12-08
Genetic Analysis announces terms of the previously announced subsequent offering to shareholders of up to appr. NOK 9 million 2023-11-30